References
Parratt JR, Vegh A (1994) Pronounced antiarrhythmic effects of ischemic preconditioning. Cardioscience 5: 9–18
Vegh A, Komori S, Szekeres L, Parratt JR (1992) Antiarrhythmic effect of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 26: 487–495
Piacentini L, Wainwright CL, Parratt JR (1993) The antiarrhythmic effect of ischaemic preconditioning in rat isolated hearts involves a pertussis toxin sensitive mechanism. Cardiovasc Res 27: 674–680
Vegh A, Papp JGy, Parratt JR (1994) Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 113: 1081–1082
Coker SJ, Parratt JR, Ledingham IMcL, Zeitlin IJ (1981) Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature 291: 323–324
Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Tada M, Inoue M, Hori M, Kamada T (1995) Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun 211: 370–374
Vegh A, Szekeres L, Parratt JR (1992) Preconditioning of the ischaemic myocardium; involvement of the Larginine nitric oxide pathway. Br J Pharmacol 107: 648–652
Vegh A, Papp JGy, Parratt JR (1994) Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors. Br J Pharmacol 113: 1167–1172
Vegh A, Kaszala K, Papp JGy, Parratt JR (1995) Delayed myocardial protection by pacing-induced preconditioning; a possible role for bradykinin. Br J Pharmacol (in press)
Vegh A, Szekeres L, Parratt JR (1990) Protective effects of preconditioning on the ischaemic myocardium involves cyclo-oxygenase products. Cardiovasc Res 24: 1020–1022
Kis A, Vegh A, Papp JGy, Parratt JR (1995) Dual blockade of the cyclooxygenase and L-arginine-nitric oxide pathways prevents the antiarrhythmic effects of preconditioning. J Molec Cell Cardiol 27: A159
Szilvassy Z, Jakab I, Lonovics J, Papp JGy (1992) Is rapid pacing-induced preconditioning related to changes of myocardial cyclic nucleotide content? J Mol Cell Cardiol 24 (Supp V): S99
Parratt JR (1995) Possibilities for the pharmacological exploitation of ischaemic preconditioning. J Mol Cell Cardiol 27: 991–1000
Wu Song, Furman BL, Parratt JR (1994) Endotoxin protection against ischaemiainduced ventricular arrhythmias is attenuated by dexamethasone. Br J Pharmac 113: 1083–1084
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parratt, J.R., Vegh, A. Endothelial cells, nitric oxide and ischaemic preconditioning. Basic Res Cardiol 91, 27–30 (1996). https://doi.org/10.1007/BF00788857
Issue Date:
DOI: https://doi.org/10.1007/BF00788857